跳至主要内容
临床试验/CTRI/2020/07/026643
CTRI/2020/07/026643招募中2 期

A Clinical study on siddha Herbomineral Formulation Swasakudori Chenduramin Silathuma kaasam(Humid asthma)

Ayothidoss Pandithar Hospital0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
2 期
状态
招募中
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1.Age 19 to 60 years
  • 2.Sex: female, male, Transgender
  • 3.Moderate persistent type of Bronchial Asthma
  • 4.Weekly twice or daily symptoms of difficulty in breathing, Tightness of chest, Wheeze - Added sound (Rhonchi), cough with or without expectoration
  • 5.FEV1/FVC reduced 5 percentage
  • 6.Exacerbation is two or more in a year
  • 7.Night time wheezing more than one day/week.
  • 8.Obstructive type of asthma
  • 9.Reversible by bronchodilators.
  • 10.Asthma sometimes interferes with normal daily activities.
  • 11.Patient who are willing to take radiological investigation and provide blood for lab investigation.
  • 12.Patient who is willing to estimate volume of air forcibly expired after a deep inspiration by using Pulmonary Function Test.

排除标准

  • 1.Restrictive lung disease
  • 2.Tuberculosis
  • 4.Lung Carcinoma and other Carcinomas
  • 5.Status asthmatics
  • 6.Emphysema
  • 7.Pleural effusion
  • 8.Cardiac disease
  • 9.Hypertension
  • 10.Renal disease
  • 11.Diabetic mellitus
  • 12.Recent abdominal, thoracic, or eye surgery
  • 13.Symptoms of acute severe illness like Chest pain, nausea, vomiting, high fever, dyspnea
  • 14.Recent hemoptysis
  • 15.Pneumothorax
  • 16.Recent history of abdominal, thoracic, or cerebral aneurysm
  • 17.Sleep apnoea
  • 18.Pregnancy
  • 19.Lactation
  • 20.Psychological factor

研究者

发起方
Ayothidoss Pandithar Hospital

相似试验